Based on the above evidence that at least one variant in CYP1B1, RAD23B, ERCC2, or GSTM1 was associated with one or more GIST mutation types at p<0.005, we provided a detailed evaluation of the estimated effects for all of the variants in these four key genes (Table 3). Here, GSTM1 is linked to gastrointestinal stromal tumor.